FC
EHC icon

Farringdon Capital’s Encompass Health EHC Stock Holding History

Farringdon Capital’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$619K Buy
+6,400
New +$656K 0.14% 202

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Farringdon Capital's EHC Position: Q1 2026 in Review

Farringdon Capital opened a new position in Encompass Health (EHC) in Q1 2026: 6,400 shares worth $619K. The stake represents 0.14% of the portfolio and ranks #202 among its holdings.

577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Farringdon Capital held 6,400 shares of Encompass Health worth $619K as of Q1 2026.
  • Encompass Health was a new Farringdon Capital position in Q1 2026.
  • Encompass Health made up 0.14% of Farringdon Capital's portfolio in Q1 2026, its #202 holding.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Farringdon Capital's 13F filing for Q1 2026, filed 15 May 2026.